Drug Profile
U 104067F
Alternative Names: PNU 104067FLatest Information Update: 28 Mar 2000
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Anti-inflammatories; Antiasthmatics; Neuroprotectants
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Neurodegenerative disorders
Most Recent Events
- 28 Mar 2000 No-Development-Reported for Neurodegenerative disorders in USA (Unknown route)
- 22 Mar 2000 No-Development-Reported for Asthma in USA (Unknown route)
- 18 Jun 1996 Phase-I clinical trials for Asthma in USA (Unknown route)